BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PDGFRB, JTK12, 5159, P09619, ENSG00000113721, PDGF-R-beta, PDGFR1, CD140B, PDGFR, CD140b AND Prognosis
25 results:

  • 1. cancer-associated fibroblasts in papillary thyroid carcinoma.
    Zhu L; Zhang X; Zhang S; Zhang Q; Cao L; Zhang Y; Wang D; Liang X; Wu W; Wu S; Jiang R; Liu Y; Zhao X; Zhou G; Xu K; Meng Z
    Clin Exp Med; 2023 Oct; 23(6):2209-2220. PubMed ID: 36715834
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features.
    Pellinen T; Paavolainen L; Martín-Bernabé A; Papatella Araujo R; Strell C; Mezheyeuski A; Backman M; La Fleur L; Brück O; Sjölund J; Holmberg E; Välimäki K; Brunnström H; Botling J; Moreno-Ruiz P; Kallioniemi O; Micke P; Östman A
    J Natl Cancer Inst; 2023 Jan; 115(1):71-82. PubMed ID: 36083003
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Targeting Podoplanin for the Treatment of Osteosarcoma.
    Takemoto A; Takagi S; Ukaji T; Gyobu N; Kakino M; Takami M; Kobayashi A; Lebel M; Kawaguchi T; Sugawara M; Tsuji-Takayama K; Ichihara K; Funauchi Y; Ae K; Matsumoto S; Sugiura Y; Takeuchi K; Noda T; Katayama R; Fujita N
    Clin Cancer Res; 2022 Jun; 28(12):2633-2645. PubMed ID: 35381070
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. High tumor cell platelet-derived growth factor receptor beta expression is associated with shorter survival in malignant pleural epithelioid mesothelioma.
    Ollila H; Paajanen J; Wolff H; Ilonen I; Sutinen E; Välimäki K; Östman A; Anttila S; Kettunen E; Räsänen J; Kallioniemi O; Myllärniemi M; Mäyränpää MI; Pellinen T
    J Pathol Clin Res; 2021 Sep; 7(5):482-494. PubMed ID: 33955203
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. pdgfr
    Hu G; Huang L; Zhong K; Meng L; Xu F; Wang S; Zhang T
    Aging (Albany NY); 2021 May; 13(10):13693-13707. PubMed ID: 33946048
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The prognostic analysis of the some clinicopathological parameters and gene protein expressions in malignant mesothelioma.
    Tohumcuoğlu M; Büyükşimşek M; Kara İO; Gümürdülü D; Bağır E
    Tuberk Toraks; 2019 Sep; 67(3):162-168. PubMed ID: 31709947
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumors.
    Ibrahim A; Chopra S
    Arch Pathol Lab Med; 2020 May; 144(5):655-660. PubMed ID: 31169996
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Systemic Treatment of Malignant Pleural Mesothelioma].
    Nakano T
    Gan To Kagaku Ryoho; 2017 Dec; 44(13):2041-2047. PubMed ID: 29361614
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma.
    Tsao AS; Lin H; Carter BW; Lee JJ; Rice D; Vaporcyan A; Swisher S; Mehran R; Heymach J; Nilsson M; Fan Y; Nunez M; Diao L; Wang J; Fujimoto J; Wistuba II; Hong WK
    J Thorac Oncol; 2018 Feb; 13(2):246-257. PubMed ID: 29313814
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. pdgfr-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways.
    Naidu S; Shi L; Magee P; Middleton JD; Laganá A; Sahoo S; Leong HS; Galvin M; Frese K; Dive C; Guzzardo V; Fassan M; Garofalo M
    Sci Rep; 2017 Nov; 7(1):15441. PubMed ID: 29133857
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs).
    Tiseo M; Damato A; Longo L; Barbieri F; Bertolini F; Stefani A; Migaldi M; Gnetti L; Camisa R; Bordi P; Buti S; Rossi G
    Lung Cancer; 2017 Feb; 104():24-30. PubMed ID: 28212996
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
    Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
    J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Concurrent radiotherapy and intrathecal methotrexate for treating leptomeningeal metastasis from solid tumors with adverse prognostic factors: A prospective and single-arm study.
    Pan Z; Yang G; He H; Zhao G; Yuan T; Li Y; Shi W; Gao P; Dong L; Li Y
    Int J Cancer; 2016 Oct; 139(8):1864-72. PubMed ID: 27243238
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [The Current Immunohistochemistry Markers in the Resected Tissues of Non-small Cell lung cancer Could Not Predict prognosis].
    Shen L; Kang X; Sun Y; Fu H; Dai L; Yan W; Chen K
    Zhongguo Fei Ai Za Zhi; 2016 Mar; 19(3):147-52. PubMed ID: 27009819
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Molecular profiling of 6,892 colorectal cancer samples suggests different possible treatment options specific to metastatic sites.
    El-Deiry WS; Vijayvergia N; Xiu J; Scicchitano A; Lim B; Yee NS; Harvey HA; Gatalica Z; Reddy S
    Cancer Biol Ther; 2015; 16(12):1726-37. PubMed ID: 26553611
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma.
    Ilhan-Mutlu A; Siehs C; Berghoff AS; Ricken G; Widhalm G; Wagner L; Preusser M
    Tumour Biol; 2016 Jan; 37(1):1173-82. PubMed ID: 26277786
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Nintedanib for the treatment of non-small-cell lung cancer.
    Rashdan S; Hanna N
    Expert Opin Pharmacother; 2014 Apr; 15(5):729-39. PubMed ID: 24597846
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Prognostic relevance of cancer-associated fibroblasts in human cancer.
    Paulsson J; Micke P
    Semin Cancer Biol; 2014 Apr; 25():61-8. PubMed ID: 24560651
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Progress of platelet derived grow factor family in non-small cell lung cancer].
    Tian Y; Chu Q; Chen Y
    Zhongguo Fei Ai Za Zhi; 2014 Jan; 17(1):42-8. PubMed ID: 24398313
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. CD99 is a novel prognostic stromal marker in non-small cell lung cancer.
    Edlund K; Lindskog C; Saito A; Berglund A; Pontén F; Göransson-Kultima H; Isaksson A; Jirström K; Planck M; Johansson L; Lambe M; Holmberg L; Nyberg F; Ekman S; Bergqvist M; Landelius P; Lamberg K; Botling J; Ostman A; Micke P
    Int J Cancer; 2012 Nov; 131(10):2264-73. PubMed ID: 22392539
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.